fda bpc-157 compounding safety risks immunogenicity Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives BPC 157 Banned: Key Facts

This isnt something most healthcare providers talk about, probably because its pretty technical and the research is still developing

Typical protocol: Dose: 12 mg subcutaneously daily Duration: 812 weeks for visible skin changes Can also be used topically (0.51% in carrier solution) KPV: The Targeted Anti-Inflammatory KPV is a tripeptide (lysine-proline-valine) derived from alpha-MSH (alpha-melanocyte-stimulating hormone)

Macrodoses of vitamin B12 are absorbed even in the absence of intrinsic factor and hydrochloric acid, as they are not dependent on these, making them a valid strategy for maintenance or recovery in processes or states where this protective protein is not being secreted, such as in gastrectomies, achlorhydria, etc

So, the better question is not which one is better? The better research question is: which peptide fits the study model